Nurse Practitioner, Acute Care · Pittsfield, MA
NPI
1144878216
Since 2019
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
725 North St
Pittsfield, MA, 01201
Phone (413) 447-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,450 services
Medicare patients, 2024
609
Average age 73
Drug cost, 2024
$2.6M
5,881 prescriptions
Company payments, 2025
$347
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nancy M Potvin was code 99214 (office e&m - established), 599 times for 392 patients. In total Nancy M Potvin billed 1,450 services in 17 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 599 | 392 | $62.08 | $37K |
| 99441 Telephone Services | Office | 180 | 133 | $36.42 | $6,556 |
| 99213 Office E&M - Established | Facility | 172 | 145 | $36.80 | $6,329 |
| 99442 Telephone Services | Office | 117 | 84 | $58.08 | $6,795 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 99 | 89 | $11.48 | $1,136 |
| 99215 Office E&M - Established | Facility | 78 | 76 | $91.95 | $7,172 |
| 99406 Behavioral Health Services | Facility | 72 | 52 | $9.60 | $691 |
| 99406 Behavioral Health Services | Office | 27 | 18 | $12.69 | $343 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 26 | 26 | $11.47 | $298 |
| 99443 Telephone Services | Office | 22 | 21 | $81.75 | $1,799 |
| 99407 Behavioral Health Services | Facility | 20 | 16 | $20.38 | $408 |
By year: 2022 $69K for 1,170 services; 2023 $71K for 1,320 services; 2024 $71K for 1,450 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nancy M Potvin prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 783 prescriptions and refills. In total Nancy M Potvin wrote 5,881 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 783 | 1,149 | 171 | $696K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 571 | 684 | 203 | $20K |
| Breo Ellipta Fluticasone/Vilanterol | 474 | 642 | 107 | $248K |
| Montelukast Sodium Generic | 400 | 771 | 98 | $4,640 |
| Ventolin Hfa Albuterol Sulfate | 355 | 455 | 97 | $29K |
| Fluticasone Propionate Generic | 330 | 507 | 127 | $5,421 |
| Prednisone Generic | 276 | 312 | 137 | $999 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 191 | 258 | 41 | $114K |
| Symbicort Budesonide/Formoterol Fumarate | 163 | 237 | 45 | $52K |
| Incruse Ellipta Umeclidinium Bromide | 152 | 224 | 36 | $74K |
| Levocetirizine Dihydrochloride Generic | 143 | 228 | 29 | $1,720 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 119 | 134 | 27 | $80K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 117 | 175 | 48 | $18K |
| Azelastine Hcl Generic | 114 | 185 | 46 | $2,190 |
| Dupixent Pen Dupilumab | 100 | 100 | 13 | $359K |
Brand drugs: 3,528 claims; generic drugs: 2,353 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nancy M Potvin $347 ($347 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genzyme Corporation with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.